1
Belgacem Haba Belgacem (Bel) Haba
Belgacem Haba: Memory module. Morgan Lewis & Bockius, June 1, 2006: US20060114661-A1

The memory module includes a substantially rigid first circuit board having at least one memory chip disposed thereon. The memory module also includes a substantially rigid second circuit board having an array of electrical contact points disposed on a planar surface thereof. A flexible connector el ...


2
Belgacem Haba Belgacem (Bel) Haba
Michael Warner, Belgacem Haba, Masud Beroz: Microelectronic assemblies incorporating inductors. Tessera, Tessera, LERNER DAVID et al, June 1, 2006: US20060113645-A1

Inductors are provided in chip assemblies such as in packaged semiconductor chips. The inductors may be incorporated in a chip carrier which forms part of the package, and may include, for example, spiral or serpentine inductors formed from traces on the chip carrier. The chip carrier may include a ...


3
Deodatta Shenai-Khatkhate
Deodatta Vinayak Shenai Khatkhate, Egbert Woelk: Organometallic compounds. Rohm and Haas Electronic Materials, S Matthew Cairns, Rohm and Haas Electronic Materials, June 1, 2006: US20060115595-A1

Compositions useful in the manufacture of compound semiconductors are provided. Methods of manufacturing compound semiconductors using these compositions are also provided.


4
Eugene Fitzgerald
David Michael Isaacson, Eugene A Fitzgerald: Method for forming low defect density alloy graded layers and structure containing such layers. Massachusetts Institute of Technology, Wolf Greenfield & Sacks PC, Federal Reserve Plaza, June 1, 2006: US20060113542-A1

A structure and method of forming same, comprising a low threading density alloy graded layer, deposited according to a deposition temperature profile in correspondence with increasing alloy composition. In one embodiment, a first substantially relaxed alloy graded layer is deposited while varying a ...


5
Noriega Gerardo V, Chechelski Victor, Sudaria Rudolfo, Carley Michael, Aganon Nestor, Coblin Eric: Guidewire for crossing occlusions or stenoses. Revascular Therapeutics, Noriega Gerardo V, Chechelski Victor, Sudaria Rudolfo, Carley Michael, Aganon Nestor, Coblin Eric, BAINS Nena, June 1, 2006: WO/2006/058223 (119 worldwide citation)

A deflectable and torqueable hollow guidewire device is disclosed for removing occlusive material and passing through occlusions, stenosis, thrombus, plaque, calcified material, and other materials in a body lumen, such as a coronary artery. The hollow guidewire generally comprises an elongate, tubu ...


6
Abildgaard Flemming: Processing a message received from a mobile cellular network. Nokia Corporation, Abildgaard Flemming, HIGGIN Paul, June 1, 2006: WO/2006/056822 (81 worldwide citation)

A portable radio communications device that has as a priority in an idle state an option to compose an MMS voice message, that has as a priority when an MMS voice message has been received an option to play the received voice message and that has as a priority when a received MMS voice message has b ...


7
Toshima Akio, Nakagawa Shigeo: Portable game holder. Toshima Akio, Nakagawa Shigeo, June 1, 2006: JP2006-136694 (76 worldwide citation)

PROBLEM TO BE SOLVED: To provide a portable game holder by which a user can bodily feel a real operation sense when using a game machine and perform exercise with fitness effect and, further, which can be constituted so that the exercise state of the body accompanying the operation is detected to pe ...


8

9
Cooke Nigel Graham, Manley Paul W: Combinations of jak inhibitors and at least one of bcr-abl, flt-3, fak or raf kinase inhibitors. Novartis, Novartis, Pharma, Cooke Nigel Graham, Manley Paul W, DE WEERD Peter, June 1, 2006: WO/2006/056399 (66 worldwide citation)

The invention provides a pharmaceutical combination comprising: a) at least one agent selected from Bcr-Abl, Flt-3, FAK and RAF kinase inhibitors; and b) at least one JAK kinase inhibitor and a method for treating or preventing a proliferative disease using such a combination.


10
Kim Sunghoon: Use of aimp2dx2 for the diagnosis and treatment of cancer. Seoul National University Industry Foundation, Kim Sunghoon, SON Min, June 1, 2006: WO/2006/057500 (63 worldwide citation)

The present invention relates to a variant of AIMP2 lacking exon 2, named as AIMP2DX2, which is specifically expressed xn cancer cells. The AIMP2DX2 protein and gene can be successfully used in the development of diagnosis and treatment of cancer.